• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清蛋白电泳与质谱联用:M 蛋白检测和定量的新工作流程。

Integrating Serum Protein Electrophoresis with Mass Spectrometry, A New Workflow for M-Protein Detection and Quantification.

机构信息

Department of Neurology, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands.

Department of Clinical Chemistry, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands.

出版信息

J Proteome Res. 2020 Jul 2;19(7):2845-2853. doi: 10.1021/acs.jproteome.9b00705. Epub 2020 Jan 14.

DOI:10.1021/acs.jproteome.9b00705
PMID:31895568
Abstract

Serum protein electrophoresis (SPE) and immunofixation electrophoresis (IFE) are standard tools for multiple myeloma (MM) routine diagnostics. M-protein is a biomarker for MM that can be quantified with SPE and characterized with IFE. We have investigated combining SPE/IFE with targeted mass spectrometry (MS) to detect and quantify the M-protein. SPE-MS assay offers the possibility to detect M-protein with higher sensitivity than SPE/IFE, which could lead to better analysis of minimal residual disease in clinical laboratories. In addition, analysis of archived SPE gels could be used for retrospective MM studies. We have investigated two different approaches of measuring M-protein and therapeutic monoclonal antibodies (t-mAbs) from SPE/IFE gels. After extracting proteotypic peptides from the gel, they can be quantified using stable isotope labeled (SIL) peptides and measured by Orbitrap mass spectrometry. Alternatively, extracted peptides can be labeled with tandem mass tags (TMT). Both approaches are not hampered by the presence of t-mAbs. Using SIL peptides, limit of detection of the M-protein is approximately 100-fold better than with routine SPE/IFE. Using TMT labeling, M-protein can be compared in different samples from the same patient. We have successfully measured M-protein proteotypic peptides extracted from the SPE/IFE gels utilizing SIL peptides and TMT.

摘要

血清蛋白电泳(SPE)和免疫固定电泳(IFE)是多发性骨髓瘤(MM)常规诊断的标准工具。M 蛋白是 MM 的生物标志物,可通过 SPE 进行定量,并通过 IFE 进行特征分析。我们研究了将 SPE/IFE 与靶向质谱(MS)相结合,以检测和定量 M 蛋白。SPE-MS 检测方法比 SPE/IFE 具有更高的检测 M 蛋白的灵敏度,这可能会导致临床实验室中对微小残留病的分析更好。此外,还可以对存档的 SPE 凝胶进行分析,以用于回顾性 MM 研究。我们研究了从 SPE/IFE 凝胶中测量 M 蛋白和治疗性单克隆抗体(t-mAb)的两种不同方法。从凝胶中提取特征肽后,可使用稳定同位素标记(SIL)肽进行定量,并通过 Orbitrap 质谱法进行测量。或者,可以用串联质量标签(TMT)标记提取的肽。这两种方法都不受 t-mAb 的存在的影响。使用 SIL 肽,M 蛋白的检测限比常规 SPE/IFE 好约 100 倍。使用 TMT 标记,可以比较同一患者不同样本中的 M 蛋白。我们已经成功地使用 SIL 肽和 TMT 测量了从 SPE/IFE 凝胶中提取的 M 蛋白特征肽。

相似文献

1
Integrating Serum Protein Electrophoresis with Mass Spectrometry, A New Workflow for M-Protein Detection and Quantification.血清蛋白电泳与质谱联用:M 蛋白检测和定量的新工作流程。
J Proteome Res. 2020 Jul 2;19(7):2845-2853. doi: 10.1021/acs.jproteome.9b00705. Epub 2020 Jan 14.
2
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference.监测接受单克隆抗体联合治疗的多发性骨髓瘤患者的 M 蛋白:消除干扰的实验室解决方案。
Clin Chem Lab Med. 2021 Aug 16;59(12):1963-1971. doi: 10.1515/cclm-2021-0399. Print 2021 Nov 25.
3
Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference.监测接受达雷妥尤单抗治疗的多发性骨髓瘤患者:揭示单克隆抗体干扰。
Clin Chem Lab Med. 2016 Jun 1;54(6):1095-104. doi: 10.1515/cclm-2015-1031.
4
Analytical sensitivity and diagnostic performance of serum protein electrophoresis on the HYDRAGEL 30 PROTEIN(E) β1-β2 Sebia Hydrasys system.血清蛋白电泳在HYDRAGEL 30 PROTEIN(E) β1-β2 Sebia Hydrasys系统上的分析灵敏度和诊断性能
Clin Biochem. 2018 Jan;51:80-84. doi: 10.1016/j.clinbiochem.2017.09.007. Epub 2017 Sep 12.
5
Identifying therapeutic monoclonal antibodies using target protein collision electrophoresis reflex assay to separate the wheat from the chaff.使用靶蛋白碰撞电泳反射分析鉴定治疗性单克隆抗体,以区分良莠。
J Immunol Methods. 2023 Nov;522:113552. doi: 10.1016/j.jim.2023.113552. Epub 2023 Aug 29.
6
Development of a Targeted Mass-Spectrometry Serum Assay To Quantify M-Protein in the Presence of Therapeutic Monoclonal Antibodies.靶向质谱血清检测法的开发,用于在存在治疗性单克隆抗体的情况下定量 M 蛋白。
J Proteome Res. 2018 Mar 2;17(3):1326-1333. doi: 10.1021/acs.jproteome.7b00890. Epub 2018 Feb 15.
7
Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.评估游离轻链检测在自体干细胞移植前后监测多发性骨髓瘤患者中的效率,并与血清蛋白电泳和血清蛋白免疫固定法进行比较。
Roum Arch Microbiol Immunol. 2011 Jan-Mar;70(1):15-22.
8
Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA).达雷妥尤单抗会干扰多发性骨髓瘤患者的血清免疫固定电泳监测,使用达雷妥尤单抗免疫固定电泳反射检测(DIRA)可消除这种干扰。
Clin Chem Lab Med. 2016 Jun 1;54(6):1105-9. doi: 10.1515/cclm-2015-0888.
9
Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.对于完整免疫球蛋白多发性骨髓瘤患者的诊断及随访,重链/轻链特异性免疫球蛋白比率相较于血清蛋白电泳和免疫固定电泳并未提供更多信息。
Pathol Biol (Paris). 2015 Sep;63(4-5):215-21. doi: 10.1016/j.patbio.2015.06.001. Epub 2015 Aug 28.
10
Pilot Verification of a Novel Approach to Remove Electrophoretic Interference of the Therapeutic Monoclonal Antibody Daratumumab.新型去除达雷妥尤单抗治疗性单克隆抗体电泳干扰方法的验证研究
J Appl Lab Med. 2022 Jun 30;7(4):910-915. doi: 10.1093/jalm/jfab174.

引用本文的文献

1
Relevance of Prescribing Serum Immunofixation Electrophoresis in the Diagnosis of Monoclonal Gammopathies.血清免疫固定电泳在单克隆丙种球蛋白病诊断中的应用相关性
Cureus. 2025 Jun 19;17(6):e86339. doi: 10.7759/cureus.86339. eCollection 2025 Jun.
2
Improved detection of tryptic immunoglobulin variable region peptides by chromatographic and gas-phase fractionation techniques.通过色谱和气相分段技术提高胰蛋白酶免疫球蛋白可变区肽的检测。
Cell Rep Methods. 2024 Jun 17;4(6):100795. doi: 10.1016/j.crmeth.2024.100795. Epub 2024 Jun 10.
3
Mass spectrometry-based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma.
基于质谱的多发性骨髓瘤维持治疗期间外周血 M 蛋白评估。
Blood. 2024 Aug 29;144(9):955-963. doi: 10.1182/blood.2024024041.
4
Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future.多发性骨髓瘤中的微小残留病:过去、现在与未来
Cancers (Basel). 2023 Jul 20;15(14):3687. doi: 10.3390/cancers15143687.
5
MALDI-TOF-MS for rapid screening analysis of M-protein in serum.基质辅助激光解吸电离飞行时间质谱用于血清中M蛋白的快速筛查分析。
Front Oncol. 2022 Dec 15;12:1073479. doi: 10.3389/fonc.2022.1073479. eCollection 2022.
6
Retrospective Longitudinal Monitoring of Multiple Myeloma Patients by Mass Spectrometry Using Archived Serum Protein Electrophoresis Gels and De Novo Sequence Analysis.使用存档血清蛋白电泳凝胶和从头测序分析通过质谱对多发性骨髓瘤患者进行回顾性纵向监测。
Hemasphere. 2022 Aug 2;6(8):e758. doi: 10.1097/HS9.0000000000000758. eCollection 2022 Aug.
7
A Comparison of gel (Hydragel 30) and capillary (Capillarys III Tera) electrophoresis for the characterization of human serum proteins.凝胶(Hydragel 30)电泳和毛细管(Capillarys III Tera)电泳用于人血清蛋白表征的比较
Pract Lab Med. 2021 Apr 29;25:e00233. doi: 10.1016/j.plabm.2021.e00233. eCollection 2021 May.
8
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report.质谱法评估多发性骨髓瘤和相关疾病中的单克隆蛋白:国际骨髓瘤工作组质谱学委员会报告。
Blood Cancer J. 2021 Feb 1;11(2):24. doi: 10.1038/s41408-021-00408-4.